Hoping for a reversal of fortune, a group of lawyers from Kline & Specter will appear tomorrow before a federal judge in Boston � the same judge who just last month harshly criticized the firm’s conduct � in the hope that he will now view the firm so favorably that he will award more than $4 million in attorney fees.
U.S. District Judge Richard G. Stearns of the District of Massachusetts recently granted final approval to a pair of settlements totaling $150 million in a class action RICO suit against TAP Pharmaceutical Products Inc. over alleged illegal sales tactics that drove up the price of the prostate cancer drug Lupron.
